Kiora Pharmaceuticals, Inc. (KPRX)
2.53
+0.02
(+0.80%)
USD |
NASDAQ |
Sep 09, 14:01
Kiora Pharmaceuticals Debt to Equity Ratio : 0.0198 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0198 |
| March 31, 2026 | 0.0268 |
| December 31, 2025 | 0.0228 |
| September 30, 2025 | 0.018 |
| June 30, 2025 | 0.0195 |
| March 31, 2025 | 0.0067 |
| December 31, 2024 | 0.0022 |
| September 30, 2024 | 0.0024 |
| June 30, 2024 | 0.0025 |
| March 31, 2024 | 0.0027 |
| December 31, 2023 | 0.0175 |
| September 30, 2023 | 0.0023 |
| June 30, 2023 | 0.0029 |
| March 31, 2023 | 0.0072 |
| December 31, 2022 | 0.0093 |
| September 30, 2022 | 0.0129 |
| June 30, 2022 | 0.0189 |
| March 31, 2022 | 0.0141 |
| December 31, 2021 | 0.0144 |
| September 30, 2021 | 0.0149 |
| June 30, 2021 | 0.0295 |
| March 31, 2021 | 0.0411 |
| December 31, 2020 | 0.059 |
| September 30, 2020 | 0.057 |
| June 30, 2020 | 0.0488 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0156 |
| December 31, 2019 | 0.0127 |
| September 30, 2019 | 0.0241 |
| June 30, 2019 | 0.0131 |
| March 31, 2019 | 0.0101 |
| December 31, 2018 | 0.0005 |
| September 30, 2018 | 0.0006 |
| June 30, 2018 | 0.0007 |
| March 31, 2018 | 0.0024 |
| December 31, 2017 | -0.0084 |
| September 30, 2017 | 0.0283 |
| June 30, 2017 | 0.0048 |
| March 31, 2017 | -0.0235 |
| December 31, 2016 | -0.1061 |
| September 30, 2016 | 0.0096 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.31 |
| September 30, 2014 | -0.289 |
| June 30, 2014 | -0.3441 |
| March 31, 2014 | -0.2695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 23.78M |
| Total Liabilities (Quarterly) | 6.919M |
| Shareholders Equity (Quarterly) | 16.86M |
| Current Ratio | 8.970 |
| Net Debt Paydown Yield | -0.30% |